Click Here to return To Results

 

Cost-Effectiveness of Recombinant Activated Factor VII in the Treatment of Intracerebral Hemorrhage Stroke 37:2751-2758, Earnshaw,S.R.,et al, 2006 See this aricle in Pubmed Article Abstract Treatment of ICH with rFVIIa 40 ?g/kg appears to be cost-effective (?$50 000/QALY). At the 80 ?g/kg dose, rFVIIa was not only cost-effective, but also cost saving.

Related Tags

(click to filter results - removes previous filter) cerebrovascular accident,cost of cost effectiveness intracerebral hemorrhage recombinant activated factor VII treatment of neurologic disorder

Click Here to return To Results